期刊文献+

他克莫司对人角质形成细胞增殖及干细胞因子分泌的影响 被引量:7

Effects of tacrolimus on cell proliferation of and secretion of stem cell factors by cultured human keratinocytes
原文传递
导出
摘要 目的探讨他克莫司对人角质形成细胞的增殖及干细胞因子(SCF)分泌的影响。方法体外HaCaT细胞(人永生化角质形成细胞)培养,用MTY和ELISA分别测定他克莫司对HaCaT细胞增殖及SCF含量的影响。结果10^3nmol/L~10^4nmol/L的他克莫司对人HaCaT细胞增殖有抑制作用。10nmol/L~10^2nmol/L的他克莫司可以促进HaCaT细胞SCF分泌量的增加;10^3nmol/L的他克莫司对HaCaT细胞SCF的分泌无影响;高浓度104nmol/L的他克莫司则可抑制HacaT细胞SCF的分泌。结论适当浓度的他克莫司能够促进角质形成细胞SCF的分泌。 Objective To study the effects of tacrolimus on the cell proliferation of and secretion of stem cell factors (SCF) by cultured human kcratinocytcs. Methods Human kcratinocytc cell line HaCaT was cultured and treated with various concentrations (0, 10, 10^2, 10^3, 10^4 nmol/L) of tacrolimus. After 48 hours of treatment, cell proliferation was measured with MTT assay , the levels of stem cell factor in the culture supcrnatant of HaCaT cells were detected with ELISA. Results Inhibited proliferation was observed in HaCaT cells treated with tacrolimus of 10^3-10^4 nmol/L. The secretion of SCF by HaCaT cells was enhanced in the presence of 10-10^2 nmol/L of tacrolimus, was inhibited in the presence of tacrolimus of 10^4 nmol/L, and remained unchanged with 10^3 nmol/L. Conclusion Certain concentrations of tacrolimus could enhance the expression of SCF in HaCaT cells, which may be associated with the efficacy of tacrolimus in the treatment of vitiligo.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2008年第6期400-402,共3页 Chinese Journal of Dermatology
关键词 白癜风 他克莫司 干细胞因子 Vitiligo Tacrolimus SCF
  • 相关文献

参考文献8

  • 1汪科,朱学骏.局部免疫调节剂他克莫司、吡美莫司在皮肤病的应用[J].药物不良反应杂志,2005,7(5):345-348. 被引量:19
  • 2Naughton GK, Reggiardo D, Bystryn JC. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol, 1986, 15(5 Pt 1 ): 978-981.
  • 3Steitz J,Wenzel J, Gaffal E, et al. Initiation and regulation of CD8^+ T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. Eur J Cell Biol, 2004, 83(11-12): 797-803.
  • 4Hirobe T. Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res, 2005, 18( 1 ): 2-12.
  • 5Oliveira SH, Lukacs NW. Stem cell factor: a hemopoietic cytokine with important targets in asthma. Curr Drug Targets Inflamm Allergy, 2003, 2(4): 313-318.
  • 6Kunisada T, Yamazaki H, Hayashi SI. Review: ligands for receptor tyrosine kinases expressed in the skin as environmental factors for melanocyte development.J Investig Dermatol Symp Proc, 2001, 6( 1 ): 6-9.
  • 7Okura M, Maeda H, Nishikawa S, et al. Effects of monoclonal anti-c-kit antibody (ACK2) on melanocytes in newborn mice. J Invest Dermatol, 1995, 105(3): 322-328.
  • 8Lan CC, Chen GS, Chiou MH, et al. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Br J Dermatol, 2005, 153(3): 498-505.

二级参考文献15

  • 1Mrowietz U, Graeber M, Brautigam M, et al. The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion[J]. Br J Dermatol, 1998, 139 (6): 992.
  • 2Schnopp C, Remling R, Mohrenschlager M, et al.Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial[J]. J Am Acad Dermatol,2002, 46: 73.
  • 3Kaliakatsou F, Hodgson TA, Lewsey JD, et al.Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus [J]. J Am Acad Dermatol,2002, 46:35.
  • 4Reich K, Vente C, Neumann C. Topical tacrolimus for pyoderma gangrenosum[J]. Br J Dermatol, 1998,139 (4): 755.
  • 5Ruzicka T, Assmann T, Homey B. Tacrolimus: The drug for the turn of the millennium[J]. Arch Dermatol,1999, 135 (5): 574.
  • 6Schreiber SL, Crabtree GR. The mechanism of action of cyclosporing A and FK-506 [J]. Immunol Today,1992, 13:136.
  • 7Panhans-Gross A, Novak N, Kraft S, et al. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506) [J]. J Allergy Clin Immunol, 2001, 107: 345.
  • 8Stuetz A, Grassberger M, Meingassner JG. Pimecrolimus ( Elidel, SDZ ASM981 ) -preclinical pharmacologic profile and skin selectivity[J]. Semin Cutan Med Surg, 2001, 20 (4): 233.
  • 9Boguniewicz M, Leung DY. Pathophysiologic mechanisms in atopic dermatitis[J]. Semin Cutan Med Surg,2001, 20 (4): 217.
  • 10Hanifin J M, Ling M R, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part Ⅰ, efficacy [J]. J Am Acad Dermatol,2001, 44(1): S28.

共引文献18

同被引文献30

  • 1白癜风临床分型及疗效标准(2003年修订稿)[J].中华皮肤科杂志,2004,37(7):440-440. 被引量:801
  • 2汪科,朱学骏.局部免疫调节剂他克莫司、吡美莫司在皮肤病的应用[J].药物不良反应杂志,2005,7(5):345-348. 被引量:19
  • 3常建民.他克莫司治疗白癜风的现状和机制[J].临床皮肤科杂志,2007,36(2):123-124. 被引量:9
  • 4Silverberg NB, Lin P, Travis L, et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol, 2004, 51(5): 760-766.
  • 5Kang HY,Choi YM. FKS06 increases pigmentation and migration of human melanocytes[J]. Br J Dermatol, 2006,155 (5) : 1037-1040.
  • 6Imokawa G,Miyagishi M,Yada Y. Endothelin-1 as a new melanogen:coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidemis[J]. J Invest Dermatrol, 1995,105( 1 ) : 32-37.
  • 7Wu CS,Yu CL. Narrow-band ultrviolet-B stimulates ptoliferation and migration of cultured melanocytes [J]. Exp Dermatrol, 2004,13 (12) : 755- 763.
  • 8Yoshida H, Kunisada T, Grimm T, et al. Review: melanocyte migra- tion and survival controlled by SCF/c-kit expression. J Investig Dermatol Symp Proc, 2001, 6(1 ): 1-5.
  • 9Lee AY, Kim NH, Choi WI, et al. Less keratinocyte-derived fac- tors related to more keratinoeyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J Invest Dermatol, 2005, 124(5 ): 976- 983.
  • 10Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-(-DeltaDeltaC (T)) Methed. Metheds, 2001, 25(4): 402-408.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部